Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-07-01 Sinha Vikas Director Grant or award · Stock Option (Right to Buy) +54,600 54,600
2022-07-01 VAN BEEK JEROEN B Chief Commercial Officer Grant or award +14,000 403,011
2022-07-01 VAN BEEK JEROEN B Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +26,000 26,000
2022-07-01 Atillasoy Ercem Grant or award +14,000 135,563
2022-07-01 Atillasoy Ercem Grant or award · Stock Option (Right to Buy) +26,000 26,000
2022-07-01 Brainard Diana Chief Executive Officer Grant or award +48,125 542,112
2022-07-01 Brainard Diana Chief Executive Officer Grant or award · Stock Option (Right to Buy) +89,375 89,375
2022-06-03 VAN BEEK JEROEN B Chief Commercial Officer Sale −515 $3.63 $2K 389,011
2022-06-03 Hallal David Director Sale −65,725 $3.67 $241K 2,077,889
2022-05-18 Brainard Diana Chief Executive Officer Sale −29,135 $4.33 $126K 492,165
2022-05-17 Bornstein Jeffrey S Director Grant or award · Stock Option (Right to Buy) +27,500 27,500
2022-05-17 Jovan-Embiricos Morana Director Grant or award · Stock Option (Right to Buy) +27,500 27,500
2022-05-17 Brenner Malcolm Director Grant or award · Stock Option (Right to Buy) +27,500 27,500
2022-05-17 GADICKE ANSBERT Director Grant or award · Stock Option (Right to Buy) +27,500 27,500
2022-05-17 Hallal David Director Grant or award · Stock Option (Right to Buy) +27,500 27,500
2022-05-17 Vera Juan Director Grant or award · Stock Option (Right to Buy) +27,500 27,500
2022-05-17 Tomasello Shawn Director Grant or award · Stock Option (Right to Buy) +27,500 27,500
2022-05-17 VAN BEEK JEROEN B Chief Commercial Officer Sale −15,262 $4.40 $67K 389,526
2022-04-26 Bornstein Jeffrey S Director Purchase +5,000 $4.64 $23K 40,197
2022-04-21 Hallal David Director Sale −4,227 $5.87 $25K 2,143,614

Page 14 of 27 · 527 trades